BASF logo

BASF

Last updated January 31, 2026
319
Innovation Areas
13,244
Inventors
154
Collaborations

P-chiral phosphine ligand coordination: BASFRecent Research Landscape

Racemic mixtures in carbonyl synthesis reduce pharmaceutical potency and increase purification costs. Precise stereochemical control via chiral ligand coordination ensures high enantiomeric purity and continuous throughput.

What technical problems is BASF addressing in P-chiral phosphine ligand coordination?

Low regioselectivity in hydroformylation

(16)evidences

Inefficient conversion and poor selectivity in the synthesis of critical C5 and C10 intermediates. Improving these yields reduces waste and feedstock costs in industrial fragrance and vitamin production.

Inefficient macrocyclic ether synthesis

(12)evidences

Inconsistent substitution patterns during the synthesis of complex ethers and chromanol derivatives. Precise control over functional group placement prevents byproduct formation and increases yield.

Low enantiomeric purity

(10)evidences

The synthesis of complex mesoionic thiazolopyrimidinium compounds often results in racemic mixtures or insufficient optical enrichment. Achieving high enantiomeric excess is critical for the biological efficacy and regulatory compliance of agrochemical or pharmaceutical active ingredients.

Low enantiomeric purity

(7)evidences

The keywords highlight the need for selective mono-hydrogenation and specific carbonyl production, indicating that uncontrolled reduction of multiple functional groups is the primary failure mode. Overcoming poor selectivity prevents the formation of unwanted byproducts and reduces purification overhead.

Low regioselectivity in heterocycle functionalization

(5)evidences

Inefficient production of chiral heterocyclic intermediates. Improving stereochemical control increases pharmaceutical precursor purity.